The design of a novel CRC 3D bioprinting workflow, validated as a platform for disease modeling and individualization of therapy. @mu_plovdiv @ctibiotech https://t.co/surgORymoi #bioprinting #bioprinter #tissueengineering #bioimpression #medical3dprinting
A Colorectal Cancer 3D Bioprinting Workflow as a Platform for Disease Modeling and Chemotherapeutic Screening. @mu_plovdiv @ctibiotech https://t.co/surgORymoi #bioprinting #bioprinter #tissueengineering #bioimpression #medical3dprinting #TheLattice #biote
"In the context of novel preclinical drug testing platforms and personalized medicines, our 3D bioprinted model can be easily readjusted to allow screening in 96-well plates without compromising the reproducibility of the bioprints" @mu_plovdiv @ctibiotech
RT @FrontBioeng: New Research: A Colorectal Cancer 3D Bioprinting Workflow as a Platform for Disease Modeling and Chemotherapeutic Screenin…